Although the mechanism by which VEGF promotes COX-2 in NSCLC cells is unknown, VEGF increases COX-2 expression in endothelial cells through the P38 MAPK and JNK signal pathways or involves the PKC and NOS pathways (28,29). The gene discussed is PRRT2; the disease is non-small cell lung carcinoma.